生产企业：Vertex Pharmaceuticals
Povetacicept is an investigational therapy developed by Vertex Pharmaceuticals for the treatment of IgA nephropathy. Vertex has completed an application for accelerated approval, with a potential regulatory decision expected by November. The therapy is also being evaluated for label expansions across several indications beyond IgA nephropathy.
Povetacicept is an investigational therapy developed by Vertex Pharmaceuticals for the treatment of IgA nephropathy. Vertex has completed an application for accelerated approval, with a potential regulatory decision expected by November. The therapy is also being evaluated for label expansions across several indications beyond IgA nephropathy.
IgA nephropathy (immunoglobulin A nephropathy), a chronic kidney disease
共 1 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
未检索到以该名称命名的专利
专利文献通常使用化学名或研发代号指代药物，而非通用名；且专利申请在提交约 18 个月后才公开，较新的药物可能尚未出现在这里。
